You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dopamine receptor occupancy

Showing 1 - 25 of 8,300
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Saint Louis (LB-102)

Completed
  • Schizophrenia
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 28, 2022

Bipolar Depression Trial in New York (Cariprazine)

Not yet recruiting
  • Bipolar Depression
  • New York, New York
    Columbia University Medical Center
Jan 23, 2023

D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer Trial in Philadelphia ([18F]FTP PET/CT)

Active, not recruiting
  • D3 Dopamine Receptor
  • +2 more
  • [18F]FTP PET/CT
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 5, 2022

Health Volunteers, Huntington Disease Trial in Leipzig (pridopidine (90 mg))

Completed
Has Results
  • Health Volunteers, Huntington Disease
  • pridopidine (90 mg)
  • Leipzig, Germany
    Teva Investigational Site 32648
Nov 18, 2021

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Alzheimer Trial in New Haven (BMS-984923)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Yale University
Oct 4, 2022

Multiple Sclerosis Trial in London (PIPE-307)

Completed
  • Multiple Sclerosis
  • London, United Kingdom
    Hammersmith Medicines Research
Oct 4, 2022

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

Cognitive Disorders Trial in Leuven (SDI-118, Placebo)

Completed
  • Cognitive Disorders
  • Leuven, Belgium
    Centre for Clinical Pharmacology, UZ Leuven
Aug 2, 2022

Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Palo Alto, California
    Stanford Medical Center
Nov 15, 2022

Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain

Suspended
  • Cocaine Abuse
  • Brain Dopamine Reactivity
  • Brain Dopamine Receptor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (risperidone)

Unknown status
  • Schizophrenia
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 6, 2020

MDD Trial in London (MIJ821)

Not yet recruiting
  • Major Depressive Disorder
  • London, United Kingdom
    Parexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)

Completed
  • Schizophrenia
  • +4 more
  • Risperidone/Olanzapine and PET scans
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jun 2, 2022

Type 2 Diabetes Trial in Uppsala (SAR425899, [68Ga] Ga-DO3A-VS-Cys40-Tuna-2 (glucagon receptor tracer), [68Ga]

Completed
  • Type 2 Diabetes Mellitus
  • Uppsala, Sweden
    Investigational Site Number 7520001
Apr 21, 2022

Healthy Volunteers Trial in Creve Coeur, Saint Louis (ITI-333)

Not yet recruiting
  • Healthy Volunteers
  • Creve Coeur, Missouri
  • +1 more
Jul 20, 2022

Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose

Recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • DME lactose pill
  • +7 more
  • Querétaro City, Queretaro, Mexico
  • +1 more
Oct 31, 2022

Anorexia Nervosa Trial in San Diego (amisulpride, bromocriptine)

Recruiting
  • Anorexia Nervosa
  • San Diego, California
    University of California San Diego
Sep 2, 2021

Validation of Receptor Occupancy Simulation

Completed
  • Dopamine Receptor Occupancy
  • +3 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 4, 2019

    Healthy Volunteers Trial in Stockholm (AZD2115, SPIRIVA, [11C]AZ13754366)

    Completed
    • Healthy Volunteers
    • Stockholm, Sweden
      Research Site
    Aug 27, 2021